Last reviewed · How we verify
GR2002 injection
At a glance
| Generic name | GR2002 injection |
|---|---|
| Sponsor | Genrix (Shanghai) Biopharmaceutical Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers (PHASE1)
- A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GR2002 injection CI brief — competitive landscape report
- GR2002 injection updates RSS · CI watch RSS
- Genrix (Shanghai) Biopharmaceutical Co., Ltd. portfolio CI